Cell Signaling Technology Logo - Extra Large

SignalSilence® Pool Caspase 3 siRNA #6411

Inquiry Info. # 6411

Please see our recommended alternatives.

    Product Specifications

    REACTIVITY

    Product Information

    Product Usage Information

    CST recommends transfection with 33 nM SignalSilence® Pool Caspase 3 siRNA. Decreased Caspase-3 expression was seen 24-72 hours post-transfection. See Protocol for transfection procedure.

    Storage

    SignalSilence® siRNA is supplied in RNAse-free water. Aliquot and store at -20ºC.

    Product Description

    SignalSilence® Pool Caspase-3 siRNA allows the researcher to specifically inhibit Caspase-3 expression using RNA interference, a method in which gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. The Caspase-3 siRNA is a hetergeneous mixture of 21-22 bp siRNAs. A 433 bp cDNA template of caspase-3 was transcribed by T7 RNA polymerase to create double-stranded RNA (dsRNA). RNase III was used to cleave the dsRNA in the presence of manganese buffer to 21-22 bp siRNA. All SignalSilence® siRNA are rigorously tested in-house and have been shown to reduce protein expression in specified cell lines.

    Background

    Caspase-3 (CPP-32, Apopain, Yama, SCA-1) is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins, such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (1). Activation of caspase-3 requires proteolytic processing of its inactive zymogen into activated p17 and p12 fragments. Cleavage of caspase-3 requires the aspartic acid residue at the P1 position (2).

    Alternate Names

    Casp 3; Casp3; Caspase-3; Caspase3

    For Research Use Only. Not for Use in Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    SignalSilence is a registered trademark of Cell Signaling Technology, Inc.
    Limited Use Label License, RNA interference: This product is licensed under European Patent 1144623 and foreign equivalents from Ribopharma AG, Kulmbach, Germany and is provided only for use in non-commercial research specifically excluding use (a) in drug discovery or drug development, including target identification or target validation, by or on behalf of a commercial entity, (b) for contract research or commercial screening services, (c) for the production or manufacture of siRNA-related products for sale, or (d) for the generation of commercial databases for sale to Third Parties. Information about licenses for these and other commercial uses is available from Ribopharma AG, Fritz-Hornschuch-Str. 9, D-95326 Kulmbach, Germany.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.